Keyphrases
Biologically Active
100%
Interleukin-12 (IL-12)
100%
Retroviral Vector
100%
Infected Cells
25%
Natural Killer Cells
16%
Internal Ribosome Entry Site
16%
Clinical Trials
8%
Gene Therapy
8%
T Cells
8%
Virus
8%
Tumor
8%
Recombinant
8%
Human Cell Lines
8%
Complementary DNA (cDNA)
8%
Tumor Immunity
8%
Interleukin-2
8%
Lymphocytes
8%
T Cell Activation
8%
Expression Level
8%
Primary Tumor
8%
Biologic Activity
8%
Biological Properties
8%
Antitumor Effect
8%
Patients with Cancer
8%
Cytolytic Activity
8%
Murine Cells
8%
Cytolytic
8%
Replication-competent Virus
8%
Polycistronic
8%
Polycistronic Transcript
8%
Encephalomyocarditis Virus
8%
Long Terminal Repeat
8%
Tumor Regression
8%
Neomycin Resistance
8%
G418 Selection
8%
Lymphokine-activated Killers
8%
Killer Activity
8%
Selectable Marker Gene
8%
Interferon Induction
8%
Tumor Cell Culture
8%
Direct Gene Transfer
8%
HP35
8%
HP40Nb
8%
Synergize
8%
Medicine and Dentistry
Interleukin 12
100%
Retrovirus Vector
100%
T Cell
16%
Natural Killer Cell
16%
Internal Ribosome Entry Site
16%
Gene Therapy
8%
Clinical Trial
8%
Neoplasm
8%
Maturation
8%
Cytokine
8%
Primary Tumor
8%
Gene Transfer
8%
Enzyme Linked Immunosorbent Assay
8%
Phytohaemagglutinin
8%
Bioassay
8%
Retroviridae
8%
Neomycin
8%
Marker Gene
8%
Interferon Induction
8%
Tumor Regression
8%
Tumor Cell Culture
8%
G418
8%
Cell Line
8%
Interleukin 2
8%
Encephalomyocarditis Virus
8%
Lymphokine
8%
Long Terminal Repeat
8%
Lymphocyte
8%
Immunology and Microbiology
Retrovirus Vector
100%
Interleukin 12
100%
Natural Killer Cell
16%
T Cell
16%
Internal Ribosome Entry Site
16%
Cell Line
8%
Encephalomyocarditis Virus
8%
ELISA
8%
Interleukin 2
8%
Maturation
8%
Lymphokine
8%
Gene Transfer
8%
Marker Gene
8%
Cell Stimulation
8%
Tumor Cell Culture
8%
Interferon Induction
8%
Cytokine
8%
Phytohaemagglutinin
8%
Retrovirus
8%
Long Terminal Repeat
8%
Lymphocyte
8%